Looking for some stem cell good news? You’ll like today’s post. One mission of this blog The Niche is to promote rigorous science-based regenerative medicine, which can lead to investigating and writing about not-so-upbeat stuff. Risky clinics. People getting hurt. Patient lawsuits. Serious FDA, FTC, or state AG regulatory developments. Such actions can be good […]
Recent stem cell & regenerative medicine good news Read More »
If you remember Monty Python, then you probably recall John Cleese. We’ll start with Cleese’s stem cell baloney. Not spam. Secret to eternal youth? John Cleese extols virtues of stem cell treatment, The Guardian. I’ve written before about John Cleese’s stem cell anti-aging efforts. As I told the author of The Guardian piece, I love
When a vendor of important reagents like antibody supplier Abcam charges big money, those high Abcam prices could negatively impact research in the long run. Some of the prices are so high that buying just a few antibodies could take up a small but meaningful slice of an entire R01 grant. Sky-high Abcam prices I’ve
Weekly reads: abundant Abcam prices, speedy aging & cancer, stemmy CAR-T, more on STAP Read More »
A new paper on stem cells for paralysis from a Mayo Clinic team has sparked a bit of legitimate hope but also some hype in the media. The publication was in Nature Communications. It is entitled “Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial.” The approach was direct injection
Perspectives on new stem cells for paralysis paper & media coverage Read More »
What is immune rejuvenation? How would that work and what would be the benefits? As we age, our immune systems can change in unhelpful and unhealthy ways. One such change is a drift in the balance of production of different kinds of immune cells. Such a shift can lead to too many of some immune
An unproven Georgia stem cell clinic called Superior Healthcare and other co-defendants recently lost a key court case. Some of you may remember that the Attorney General (AG) of Georgia Chris Carr and the FTC have been collaborating on this case. Now we have the good news that they have won the case via a
Georgia AG & FTC win Superior Healthcare stem cell clinic case, seek $17 million Read More »
So many things go wrong during the lead up to clinically-evident Alzheimer’s disease. This complex disease pathway has, in turn, led to a vast array of approaches to try to treat or prevent Alzheimer’s. Most of these efforts one way or another have something to do with the amyloid plaques and tangles that accumulate in the
The Mayo Clinic does some great research on stem cells and regenerative medicine. However, at times I’ve felt that a few Mayo researchers are overexuberant. This mainly relates to certain not-yet-proven stem cell and related offerings. Fitting with that perception, the Mayo website also has some inaccurate stem cell content that leans toward overstating things.
Key Mayo Clinic stem cell webpage is overexuberant & outdated Read More »
Anti-aging might already be the big regenerative medicine story of 2024 and it’s only early March. Anti-aging hype going to the dogs? One of my 20 stem cell and regenerative medicine predictions for 2024 was that longevity would continue to make big news including in some not-so-great ways. In just over two months there has
Utah appears ready to pass a new stem cell law that would explicitly allow clinical use of non-FDA-approved placental cell drug therapies in the state. Bill 199 seems likely to set up a conflict with the FDA that may land in court. The key part of the bill says: “A health care provider whose scope